Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission

INTRODUCTION: Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most prevalent cause of familial and sporadic Parkinson's disease (PD). Because most pathogenic LRRK2 mutations result in enhanced kinase activity, it suggests that LRRK2 inhibitors may serve as a potential treatment for PD...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CNS Neurosci Ther
Asıl Yazarlar: Qin, Qi, Zhi, Lian‐Teng, Li, Xian‐Ting, Yue, Zhen‐Yu, Li, Guo‐Zhong, Zhang, Hui
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2016
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248597/
https://ncbi.nlm.nih.gov/pubmed/27943591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12660
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller